Clinical Trial Update: Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) [Phase 2]

View source ↗

Summary

A Phase 2 trial (PESUP) evaluating pancreatic enzyme supplementation in unresectable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED